On Monday, Shares of Companhia Siderurgica Nacional (ADR)(NYSE:SID), added 6.88% and closed at $2.95 in the last trading session. The last trading range of the stock ranges between $2.78 and $2.96. Companhia Siderúrgica Nacional operates as an integrated steel producer in Brazil. It operates through five segments: Steel, Mining, Logistics, Cement, and Energy. It offers flat steel; slabs; hot-rolled products, counting heavy and light-gauge hot-rolled coils and sheets; cold-rolled products comprising cold-rolled coils and sheets; galvanized sheets and coils; tin mill products that consist of flat-rolled low-carbon steel coils or sheets; profiles, sections, channels, UPE sections, and steel sleepers; and long steel products. The company mainly explores for iron ore reserves at Casa de Pedra mine located in the city of Congonhas in the state of Minas Gerais, Brazil. It sells iron ore products in Asia, Europe, and Brazil. The company also engages in logistics business comprising railway and port facilities; produces and sells cement; and generates electric power from its thermoelectric co-generation and hydroelectric power plants. The company also exports its products.
Amgen, Inc. (NASDAQ:AMGN), jumped 0.32% and closed at $167.34 in the last trading session. The last trading range of the stock ranges between $164.44 and $167.58. The company’s Market capitalization is $126.26 Billion with the total Outstanding Shares of 748.36 Billion. Amgen (AMGN) recently declared that the Journal of Clinical Oncology (JCO) published results from the Phase 1/2 ‘205 single-arm trial evaluating BLINCYTO® (blinatumomab) in pediatric patients with Philadelphia chromosome‑negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Based on data from an exploratory pooled analysis of 70 patients who received the recommended dose of BLINCYTO in the Phase 1 or Phase 2 portions of the study, 27 patients (39 percent, 95 percent confidence interval [CI], 27–51 percent) achieved complete remission within the first two cycles.
The most frequent grade ≥3 adverse events (AEs) among the patients who received the recommended dose were anemia (36 percent), thrombocytopenia (21 percent), febrile neutropenia (17 percent), hypokalemia (17 percent) and neutropenia (17 percent). The most common AEs overall were pyrexia (80 percent), anemia (41 percent), nausea (33 percent) and headache (30 percent).
“This study showed that BLINCYTO can induce deep molecular remissions in children with highly refractory, multiply relapsed ALL,” said senior author Lia Gore, M.D., professor of Pediatrics, Medical Oncology and Hematology, University of Colorado Anschutz Medical Campus.
Lennar Corporation (NYSE:LEN), lost -0.47% and closed at $42.10 in the last trading session. The last trading range of the stock ranges between $41.79 and $42.19. During the 52-week trading session the minimum price at which share price traded, registered at $37.14 and reached to max level of $52.50. Lennar Corporation, together with its auxiliaries, engages in the homebuilding activities in the United States. The company operates through Homebuilding East, Homebuilding Central, Homebuilding West, Homebuilding Southeast Florida, Homebuilding Houston, and Homebuilding Other segments. Its homebuilding activities mainly include the construction and sale of single-family attached and detached homes to first-time, move-up, and active adult homebuyers, in addition to the purchase, development, and sale of residential land. The company also offers real estate related financial services, counting mortgage financing, title insurance, and closing services for home buyers and others, in addition to personal lines, property, and casualty insurance products. In addition, it is involved in raising, investing, and managing third party capital; and originating and selling into securitizations commercial mortgage loans, in addition to investing in real estate related mortgage loans, properties, and related securities. Further, the company sponsors, invests, and manages private equity vehicles, and provides asset administration and other services to the vehicles and other third parties.